(July 12, 2023, 1:50 PM EDT) -- BRIDGEPORT, Conn. — A company harnessing artificial intelligence (AI) to identify new uses for existing medications continued to release positive statements about its upcoming drug and failed to disclose that it lacked the necessary controls and that underlying problems with clinical trials would delay the release, a securities class action in a federal Connecticut court alleges....